Mineralys Therapeutics expands board with new independent directors
at www.tipranks.com (Mon, 19-Oct 4:59 PM)
Mineralys highlights lorundrostat’s blood-pressure target success: 46% reached <130 mmHg in Launch-HTN
Market Chameleon (Mon, 12-Oct 11:54 AM)
